Allogene Therapeutics (ALLO) Announces Pricing of $110 million Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. TSLA

Go back to Allogene Therapeutics (ALLO) Announces Pricing of $110 million Offering of Common Stock

Truist Securities Reiterates Buy Rating on Allogene (ALLO)

May 14, 2024 8:03 AM EDT

Truist Securities analyst Asthika Goonewardene reiterated a Buy rating and $17.00 price target on Allogene (NASDAQ: ALLO)

The analyst comments "Two key positives from 1Q24 should make the stock more attractive, in our view: (1) Gaining EU/UK rights to lead asset... More